Effect of uncontrolled hyperglycemia on levels of adhesion molecules in patients with diabetes mellitus type 2

Journal of Zhejiang University: Science B

Volumn 16, Issue 5, 2015, Pages 355-361

  Ruszkowska Ciastek, Barbara ^a   Sokup, Alina ^a   Wernik, Tomasz ^a   Ruprecht, Zofia ^a   Góralczyk, Barbara ^a   Góralczyk, Krzysztof ^a   Gadomska, Grażyna ^a   Rość, Danuta ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Diabetic kidney disease; Glomerular filtration rate; Hyperfiltration

Indexed keywords

CREATININE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEMOGLOBIN A1C; INTERCELLULAR ADHESION MOLECULE 1; THROMBOMODULIN; VASCULAR CELL ADHESION MOLECULE 1; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; ICAM1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES CONTROL; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; ANALYSIS; BLOOD; GLUCOSE BLOOD LEVEL; METABOLISM; OXIDATIVE STRESS;

AGED; BLOOD GLUCOSE; CREATININE; DIABETES MELLITUS, TYPE 2; E-SELECTIN; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; OXIDATIVE STRESS; THROMBOMODULIN; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84929177750     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1400218     Document Type: Article

References (20)

1. Booth, G., Stalker, T.J., Lefer, A.M., et al., 2002. Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo. Diabetes, 51(5):1556–1565. [doi:10.2337/diabetes.51.5.1556]
2. Bruno, C.M., Valenti, M., Bertino, G., et al., 2008. Plasma ICAM-1 and VCAM-1 levels in type 2 diabetic patients with and without microalbuminuria. Minerva. Med., 99(1):1–5.
3. Empen, K., Frost, R.J., Geiss, H.C., et al., 2003. Differential effect of fenofibrate versus atorvastatin of E-selectin and vascular cellular adhesionmolecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trial. Cardiovasc. Diabetol., 2:17. [doi:10.1186/1475-2840-2-17]
4. Glowinska, I., Malyszko, J., 2008. Cardiovascular complications in patients with diabetic nephropathy. Przegl. Kardiodiab., 3(3):217–222 (in Polish).
5. Glowinska-Olszewska, B., Urban, M., Peczynska, J., et al., 2007. Analysis of selected new biomarkers of early atherosclerosis process in children and adolescents with diabetes type 1. Przegl. Kardiodiab., 2:146–153 (in Polish).
6. Grande, M.T., Pérez-Barriocanal, F., López-Novoa, J.M., 2010. Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy. J. Inflamm., 7(1):19. [doi:10.1186/1476-9255-7-19]
7. Güler, S., Cakir, B., Demirbas, B., et al., 2002. Plasma soluble intercellular adhesion molecule 1 levels are increased in type 2 diabetic patients with nephropathy. Horm. Res., 58(2):67–70. [doi:10.1159/000064664]
8. Hadi, A.R., Suwaidi, J., 2007. Endothelial dysfunction in diabetes mellitus. Vasc. Health Risk Manag., 3(6):853–876.
9. Karalliedde, J., Gnudi, L., 2011. Endothelial factors and diabetic nephropathy. Diabetes Care, 34(Suppl. 2):S291–S296. [doi:10.2337/dc11-s241]
10. Lu, J., Randell, E., Hun, Y., et al., 2011. Increased plasma methylglyoxal level, inflammation, and vascular endothelial dysfunction in diabetic nephropathy. Clin. Bioch., 44(4):307–311. [doi:10.1016/j.clinbiochem.2010.11.004]
11. Luis-Rodríguez, D., Martínez-Castelao, A., Górriz, J.L., et al., 2012. Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. World J. Diabetes, 3(1):7–18. [doi:10.4239/wjd.v3.i1.7]
12. Mizia-Stec, K., Gasior, Z., Zahorska-Markiewicz, B., et al., 2003. Immune activation in diabetes type 2 in patients with coronary artery disease. Diabetologia Doswiadczalna i Kliniczna, 3(6):523–529 (in Polish).
13. Morcos, M., Borcea, V., Isermann, B., et al., 2001. Effect of α-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res. Clin. Pract., 52(3):175–183. [doi:10.1016/S0168-8227(01)00223-6]
14. Nadar, S., Blann, A.D., Lip, G.Y., 2004. Endothelial dysfunction: methods of assessment and application to hypertension. Curr. Pharm. Des., 10(29):3591–3605. [doi:10.2174/1381612043382765]
15. Pupek-Musialik, D., Bogdanski, P., Dytfeld, J., et al., 2005. Assesment of tumor necrosis factor soluble receptor type 2 (sTNFR2) and soluble intercellular adhesion molecule 1 (sICAM-1) in obese patients with metabolic syndrome. Inflammatory process in metabolic syndrome. Endokrynol. Otyl. Zaburz. Przem. Materii, 1(1):30–35 (in Polish).
16. Salker, T.J., Skvarka, C.B., Scalia, R., 2003. A novel role for calpains in the endothelial dysfunction of hyperglycemia. FASEB J., 17(11):1511–1513. [doi:10.1096/fj.02-1213fje]
17. Stehouwer, C.D., Gall, M.A., Twisk, J.W., et al., 2002. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes, 51(4):1157–1165. [doi:10.2337/diabetes.51.4.1157]
18. Szmit, S., Opolski, G., 2006. Diabetic microangiopathy—a current look at the pathogenesis and the clinical implications for cardiovascular diseases. Przegl. Kardiodiab., 1(1):27–34 (in Polish).
19. Thorand, B., Baumert, J., Chambless, L., et al., 2006. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population. Arterioscler. Thromb. Vasc. Biol., 26(2):398–405. [doi:10.1161/01.ATV.0000198392.05307.aa]
20. Żukowska-Szczechowska, E., Wystrychowski, G., 2007. Diabetic nephropathy and cardiovascular risk. Przegl. Kardiodiab., 2(4):209–213 (in Polish).